FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2767182937> ?p ?o ?g. }

• W2767182937 endingPage "2062" @default.
• W2767182937 startingPage "2053" @default.
• W2767182937 abstract "Background Polycystic ovarian syndrome (PCOS) affects up to 18% of reproductive-aged women with increased risks of cardiovascular disease and venous thromboembolic disease, related to metabolic and hormonal features, obesity and an apparent hypofibrinolytic state, possibly exacerbated by current PCOS treatments. Objective To investigate and compare haemostatic impacts of common pharmacological treatments and explore relationships with hormonal and metabolic variables in PCOS. Patients/Methods This mechanistic sub-study using biobanked samples from a 6-month randomized comparative trial of pharmacological treatments assessed pro- and anti-thrombotic markers and overall haemostatic activity. Overweight women of mean age 33.9 ± 6.7 years and mean BMI (body mass index) of 36.5 ± 7.0 kg/m2 with PCOS (n = 60) were randomized to either metformin, higher-dose oral contraceptive pill (OCP) or low-dose OCP + spironolactone (OCP + S). Primary outcome measures included changes in plasminogen activator inhibitor 1 (PAI-1), asymmetric dimethylarginine (ADMA), prothrombin fragments 1 and 2 (PF1 and 2), plasminogen, tissue plasminogen activator (tPA), thrombin activatable fibrinolysis inhibitor (TAFI) and thrombin generation (TG). Results PAI-1 activity fell in all groups, ADMA fell in higher-dose OCP, PF1 and 2 increased with metformin and higher-dose OCP, TG rose and tPA fell in both OCP groups, plasminogen increased in all and TAFI increased after higher-dose OCP. Conclusion Endothelial function (primary haemostasis) improved with higher dose with some improvement in low-dose OCP + S and metformin. Aberrant coagulation was noted in both OCP groups, but not with metformin. Fibrinolysis was reduced with higher-dose OCP. Our work suggests an additional dimension of treatment (haemostatic system effects) that favours metformin treatment over the OCP in PCOS." @default.
• W2767182937 created "2017-11-10" @default.
• W2767182937 creator A5011456698 @default.
• W2767182937 creator A5022380857 @default.
• W2767182937 creator A5075905415 @default.
• W2767182937 creator A5081581610 @default.
• W2767182937 date "2017-01-01" @default.
• W2767182937 modified "2023-09-26" @default.
• W2767182937 title "Differential Effects on Haemostatic Markers by Metformin and the Contraceptive Pill: A Randomized Comparative Trial in PCOS" @default.
• W2767182937 cites W1128977061 @default.
• W2767182937 cites W1582948480 @default.
• W2767182937 cites W1836408129 @default.
• W2767182937 cites W1948854550 @default.
• W2767182937 cites W1963699656 @default.
• W2767182937 cites W1980938549 @default.
• W2767182937 cites W1983899749 @default.
• W2767182937 cites W2007468076 @default.
• W2767182937 cites W2011413643 @default.
• W2767182937 cites W2016271837 @default.
• W2767182937 cites W2017763034 @default.
• W2767182937 cites W2027181611 @default.
• W2767182937 cites W2035781382 @default.
• W2767182937 cites W2036034959 @default.
• W2767182937 cites W2041423220 @default.
• W2767182937 cites W2045253522 @default.
• W2767182937 cites W2050697986 @default.
• W2767182937 cites W2054117560 @default.
• W2767182937 cites W2062896341 @default.
• W2767182937 cites W2064315460 @default.
• W2767182937 cites W2074892672 @default.
• W2767182937 cites W2077675717 @default.
• W2767182937 cites W2091790488 @default.
• W2767182937 cites W2098409670 @default.
• W2767182937 cites W2103739299 @default.
• W2767182937 cites W2104806540 @default.
• W2767182937 cites W2108067228 @default.
• W2767182937 cites W2113616720 @default.
• W2767182937 cites W2119008227 @default.
• W2767182937 cites W2119528953 @default.
• W2767182937 cites W2124623256 @default.
• W2767182937 cites W2127881358 @default.
• W2767182937 cites W2137955943 @default.
• W2767182937 cites W2140645833 @default.
• W2767182937 cites W2142327121 @default.
• W2767182937 cites W2144346444 @default.
• W2767182937 cites W2153137569 @default.
• W2767182937 cites W2165138742 @default.
• W2767182937 cites W2165465548 @default.
• W2767182937 cites W2172288279 @default.
• W2767182937 cites W2186218348 @default.
• W2767182937 cites W2312192686 @default.
• W2767182937 cites W2340718706 @default.
• W2767182937 cites W2374459079 @default.
• W2767182937 cites W2406616726 @default.
• W2767182937 cites W2539769384 @default.
• W2767182937 cites W578678826 @default.
• W2767182937 cites W59807487 @default.
• W2767182937 doi "https://doi.org/10.1160/th17-04-0248" @default.
• W2767182937 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29202210" @default.
• W2767182937 hasPublicationYear "2017" @default.
• W2767182937 type Work @default.
• W2767182937 sameAs 2767182937 @default.
• W2767182937 citedByCount "7" @default.
• W2767182937 countsByYear W27671829372019 @default.
• W2767182937 countsByYear W27671829372021 @default.
• W2767182937 countsByYear W27671829372023 @default.
• W2767182937 crossrefType "journal-article" @default.
• W2767182937 hasAuthorship W2767182937A5011456698 @default.
• W2767182937 hasAuthorship W2767182937A5022380857 @default.
• W2767182937 hasAuthorship W2767182937A5075905415 @default.
• W2767182937 hasAuthorship W2767182937A5081581610 @default.
• W2767182937 hasConcept C126322002 @default.
• W2767182937 hasConcept C134018914 @default.
• W2767182937 hasConcept C168563851 @default.
• W2767182937 hasConcept C185592680 @default.
• W2767182937 hasConcept C2776825266 @default.
• W2767182937 hasConcept C2777468819 @default.
• W2767182937 hasConcept C2779306644 @default.
• W2767182937 hasConcept C2779679481 @default.
• W2767182937 hasConcept C2779877776 @default.
• W2767182937 hasConcept C2780221984 @default.
• W2767182937 hasConcept C2780323712 @default.
• W2767182937 hasConcept C2780675426 @default.
• W2767182937 hasConcept C515207424 @default.
• W2767182937 hasConcept C55493867 @default.
• W2767182937 hasConcept C71924100 @default.
• W2767182937 hasConceptScore W2767182937C126322002 @default.
• W2767182937 hasConceptScore W2767182937C134018914 @default.
• W2767182937 hasConceptScore W2767182937C168563851 @default.
• W2767182937 hasConceptScore W2767182937C185592680 @default.
• W2767182937 hasConceptScore W2767182937C2776825266 @default.
• W2767182937 hasConceptScore W2767182937C2777468819 @default.
• W2767182937 hasConceptScore W2767182937C2779306644 @default.
• W2767182937 hasConceptScore W2767182937C2779679481 @default.
• W2767182937 hasConceptScore W2767182937C2779877776 @default.
• W2767182937 hasConceptScore W2767182937C2780221984 @default.
• W2767182937 hasConceptScore W2767182937C2780323712 @default.
• W2767182937 hasConceptScore W2767182937C2780675426 @default.

• next